• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用胆红素吸附材料进行血浆吸附治疗肝衰竭患者。

Plasma adsorption using bilirubin-adsorbent materials as a treatment for patients with hepatic failure.

作者信息

Morimoto T, Matsushima M, Sowa N, Ide K, Sawanishi K

机构信息

Division of Artificial Kidney, Kyoto University Hospital, Japan.

出版信息

Artif Organs. 1989 Oct;13(5):447-52. doi: 10.1111/j.1525-1594.1989.tb01556.x.

DOI:10.1111/j.1525-1594.1989.tb01556.x
PMID:2803055
Abstract

In order to achieve a higher degree of improvement in patients with postoperative hepatic failure, the effects of plasma adsorption (PA) using a serial connection of noncoated charcoal (N 350) and a new bilirubin adsorbent material, styrenedivinylbenzene (BR350), were investigated both experimentally and clinically. After in vitro perfusion of high bilirubin containing plasma through these columns for 3 hours, total bilirubin levels were drastically reduced to 21% of the preperfusion level in the serial connection of N 350 and BR 350, while it remained high at over 40% in the single use of each column. Total branched chain and aromatic amino acid levels were also drastically reduced in the serial connection of these columns to 50, 40, and 7%, respectively, while the total amino acid levels remained high at 87% in the single use of BR 350. The combination of these columns enhanced rather than interfered with one another. Patients who received this treatment achieved an initial reduction of plasma total bilirubin and aromatic amino acids of 57 +/- 6 and 84 +/- 7, respectively. Although the long-term prognosis for these patients was negative, improvement of clinical and laboratory findings were actually obtained by this treatment. This PA system could provide a possibility for an improved supportive therapy for hepatic failure, especially for patients with hepatic coma and hyperbilirubinemia.

摘要

为了使术后肝衰竭患者获得更高程度的改善,对使用未包被活性炭(N 350)和新型胆红素吸附材料苯乙烯二乙烯基苯(BR350)串联的血浆吸附(PA)效果进行了实验和临床研究。将含高胆红素的血浆在体外通过这些柱体灌注3小时后,在N 350和BR 350串联的情况下,总胆红素水平急剧降至灌注前水平的21%,而单独使用每个柱体时总胆红素水平仍高达40%以上。在这些柱体串联的情况下,总支链氨基酸和芳香族氨基酸水平也分别急剧降至50%、40%和7%,而单独使用BR 350时总氨基酸水平仍高达87%。这些柱体的组合起到了增强而非相互干扰的作用。接受该治疗的患者血浆总胆红素和芳香族氨基酸水平最初分别降低了57±6和84±7。尽管这些患者的长期预后不佳,但该治疗确实使临床和实验室检查结果得到了改善。这种PA系统为改善肝衰竭的支持治疗提供了可能性,特别是对于肝昏迷和高胆红素血症患者。

相似文献

1
Plasma adsorption using bilirubin-adsorbent materials as a treatment for patients with hepatic failure.使用胆红素吸附材料进行血浆吸附治疗肝衰竭患者。
Artif Organs. 1989 Oct;13(5):447-52. doi: 10.1111/j.1525-1594.1989.tb01556.x.
2
Plasma separation and bilirubin adsorption after complicated liver transplantation: a therapeutic approach to excessive hyperbilirubinemia.复杂肝移植术后的血浆分离与胆红素吸附:一种治疗重度高胆红素血症的方法
Transplantation. 1998 Feb 15;65(3):434-7. doi: 10.1097/00007890-199802150-00025.
3
Bilirubin adsorption column Medisorba BL-300.胆红素吸附柱Medisorba BL - 300
Ther Apher Dial. 2003 Feb;7(1):98-103. doi: 10.1046/j.1526-0968.2003.00007.x.
4
[Plasma separation and bilirubin adsorption therapy in excessive hyperbilirubinemia after liver transplantation].肝移植术后高胆红素血症的血浆分离及胆红素吸附治疗
Langenbecks Arch Chir Suppl Kongressbd. 1998;115:1563-5.
5
Assessment of bilirubin clearance capacity of a newly developed ion-exchange adsorption column and its possible use as a supportive therapy in hepatorenal syndrome.评估一种新开发的离子交换吸附柱的胆红素清除能力及其在肝肾综合征中作为支持性治疗的可能用途。
J Clin Apher. 1990;5(3):123-7. doi: 10.1002/jca.2920050302.
6
In vivo and in vitro evaluation of bilirubin removal in postoperative hyperbilirubinemia patients.术后高胆红素血症患者胆红素清除的体内和体外评估
Artif Organs. 1995 Jan;19(1):102-5. doi: 10.1111/j.1525-1594.1995.tb02254.x.
7
Artificial liver support for postoperative hepatic failure with anion exchange resin (BR-601).使用阴离子交换树脂(BR-601)对术后肝衰竭进行人工肝支持
Acta Med Okayama. 1986 Oct;40(5):249-55. doi: 10.18926/AMO/31928.
8
Temperature effect on bilirubin adsorption with the anion exchange resin BR-601.温度对阴离子交换树脂BR - 601吸附胆红素的影响
Int J Artif Organs. 1989 Oct;12(10):659-63.
9
Extracorporeal methods of liver failure treatment.肝衰竭治疗的体外方法。
Biomater Artif Cells Artif Organs. 1987;15(4):667-75.
10
Bilirubin adsorbent column for plasma perfusion.用于血浆灌注的胆红素吸附柱。
Ther Apher. 1998 May;2(2):129-33. doi: 10.1111/j.1744-9987.1998.tb00090.x.

引用本文的文献

1
Hydroxyapatite reinforced inorganic-organic hybrid nanocomposite as high-performance adsorbents for bilirubin removal and in pig models.羟基磷灰石增强无机-有机杂化纳米复合材料作为用于去除胆红素的高性能吸附剂及在猪模型中的应用
Bioact Mater. 2021 May 24;6(12):4772-4785. doi: 10.1016/j.bioactmat.2021.05.017. eCollection 2021 Dec.
2
Acute kidney injury spectrum in patients with chronic liver disease: Where do we stand?慢性肝病患者的急性肾损伤谱:我们处于什么位置?
World J Gastroenterol. 2019 Jul 28;25(28):3684-3703. doi: 10.3748/wjg.v25.i28.3684.
3
Prognosis of acute-on-chronic liver failure patients treated with artificial liver support system.
人工肝支持系统治疗慢性重型肝炎患者的预后
World J Gastroenterol. 2015 Aug 28;21(32):9614-22. doi: 10.3748/wjg.v21.i32.9614.
4
Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.肝肾综合征:急性透析质量倡议 (ADQI) 第 8 次国际共识会议专家组报告。
Crit Care. 2012 Feb 9;16(1):R23. doi: 10.1186/cc11188.
5
Bioartificial liver support anno 2001.
Metab Brain Dis. 2002 Dec;17(4):485-91. doi: 10.1023/a:1021990725508.